Conversely, a transgenic over-expression of c-Myc in different tissues (e.g. liver, breast) causes neoplastic diseases (particularly lymphomas) [33], illustrating the potency of c-Myc as an oncogene. This evidence concerns the gene MYC and neoplasm.